Dr. Sandeepta Burgula is a professor at the Department of Microbiology and was the former Director, Central Facilities for Research and Development at Osmania University, Hyderabad, India. The main thrust area of her research is studies involving molecular pathogenesis. Her laboratory is currently focused on utilizing bacterial enzymes for isolating bioactive peptides from biological sources. Her lab is also works on elucidating the acute phase response in bacterial sepsis and evaluating anti-tumor and anti-microbial activity of medicinal plants and biogenic nanoparticles. She has filed three Indian patents out of which one has been awarded recently. She is a former ASM-INDOUSSTF sponsored Visiting Research Professor under which she worked at St. Jude Children’s Cancer Research Hospital at Memphis, USA, and has also worked as a UGC sponsored Raman Postdoctoral Fellow in USA (SUNY, Stonybrook, NY), on Epstein-Barr virus mediated STAT3 signalling. She is an Associate Fellow of the Telangana Academy of Sciences, India.